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Abstract
In this work, Co–Sn–Cu oxides/graphene nanocomposite, 30–40 � 0.5 nm in size, was
synthesized by solid‐state microwave irradiation. This method presents several advantages
such as operational simplicity, fast, low cost, safe and energy efficient, and suitability for
production of high purity of nanoparticles. Other advantages of this method are there is
no need for the use of solvent, fuel, and surfactant. Co–Sn–Cu oxides/graphene nano-
composites have been characterized by Fourier transform infrared spectroscopy, X‐ray
diffraction, field emission scanning electron microscopy, transmission electron mic-
roscopy, vibrating sample magnetometer, energy‐dispersive X–ray spectroscopy, and
UV–Vis spectroscopy. The synthesized nanocomposites were used as novel highly effi-
cient catalysts for the synthesis of 1,8‐dioxo‐octahydroxanthenes at room temperature.
The catalysts are recoverable and can be reused for six runs without loss of their activity.
Also, the obtained nanocomposites exhibited significant anticancer activity against breast
cancer cells and they could induce apoptosis in cancer cells.
1 | INTRODUCTION
Graphene and graphene oxide (GO) have been widely used to
fabricate various kinds of composite materials and also for
catalysis synthesis due to their high surface area, high chemi-
cally stability, strong conductivity for electron transfer, and low
cost [1, 2]. Among these, graphene supported metal nano-
composites has received more attention [3]. For example,
bimetallic Sn‐W oxides/graphene and tin–zirconia/grapheme
nanocomposites have been reported as heterogeneous catalysts
for selective oxidation of alcohols [4] and synthesis of dimethyl
carbonate [5], respectively. However, despite many examples of
immobilized metal nanocomposites, little is established on
their usage as a catalyst in organic transformations.
Natural products with a xanthene moiety have revealed
biological activities such as anti‐inflammatory [6], anti‐bacterial
[7], and anti‐cancer activities [8] (Scheme 1). 1,8‐Dioxo‐
octahydroxanthenes are one of the most important derivatives
of xanthenes which were usually synthesized via one‐pot
Knoevenagel condensation, Michael addition, and
cyclodehydration of 5,5‐dimethyl‐1,3‐cyclohexanedione (dime-
tnqh_9;done) with various aldehydes. Numerous Lewis and
Brönsted acid catalysts have been used to promote this reac-
tion [9–20]. Although these catalysts are suitable for certain
synthetic conditions, their main disadvantages are long reaction
times, tedious work‐up, the formation of uncyclized adduct
2,2’‐aryl‐methylene bis(3‐hydroxy‐2‐cyclohexene‐1‐one), and
the use of unrecyclable, hazardous, or difficult to handle cat-
alysts. The need to high temperatures [9–16] or an additional
energy (ultrasound or microwave) [17, 18] is another drawback
of many of these methods. These reactions are rarely carried
out at low temperature [19, 20]. Hence, the development of
new catalysts with more efficiency is still in demand.
Transition metals have been received much attention from
the biological point of view because they are the key linkers of
complex proteins or enzymes [21, 22]. The mechanism of
action of the bivalent cationic metalloestrogens in breast can-
cer has been reviewed recently [23]. Metal‐based compounds
including copper and tin have been surveyed with promising
chemotherapeutic potential for the treatment of a range of
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cancers [24–27]. Because of the great potential of copper and
tin complexes as anticancer agents, complexes made up of both
metals have attracted much attention due to a plausible dual
mode of action at the molecular level [28]. For instance, the
chiral L‐tryptophan‐derived [bis(1,2‐diaminobenzene) copper
(II)] chloride complex, CuSn2(Trp), showed antitumor activity
[29] as well as induced cytotoxicity in PA‐1, PC‐3, HeLa,
U2OS, HepG2, and MCF‐7 cancer cell lines [30]. In addition,
cobalt‐based ligand complexes have a wide spectrum of bio-
logical activities as antibacterial and antiviral properties [31].
Cobalt‐doped magnetite, iron–cobalt/ferrite core–shell struc-
tures, and cubic iron–cobalt nanoparticles have been used for
hyperthermia application in cancer therapy [32–34]. Also, the
efficiency of graphitic carbon–cobalt nanoparticles as localized
radio frequency absorbers for cancer treatment has been
investigated [35].
Breast cancer is one of the main health concerns facing our
society and is the second leading cause of morbidity and
mortality among women worldwide [36]. For clinical treatment
of breast cancer, in many occasions chemotherapy is one
important option. Nanotechnology is on the route to providing
novel developments in medicine science, such as designing
biocompatible inorganic nanomaterials with applications of
determination of drug [37] and anti‐oxidant [38], anti‐bacterial
[39], and anti‐biofilm properties [40]. In addition, nanotech-
nology has attracted attention in tumor imaging and cancer
therapy and in this regard nanoparticles with many unique
properties, such as a high surface area‐to‐volume ratio and
magnetic and optical properties, play important roles [41]. In
this regard, the graphene‐based nanomaterials have attracted
considerable interest in upcoming nanotechnology‐based
medicine applications [42]. For instance, GO as a carrier for
adriamycin in cancer drug resistance [43] and the effect of
curcumin‐reduced GO on breast cancer cells [44] have been
investigated. GO–silver nanocomposite [45] and gallic acid/
CdS on the GO nanosheets [46] were used for targeted therapy
of human ovarian cancer stem cells and treatment of kidney
tumor cells, respectively. Tamoxifen citrate on reduced GO
nanosheets was used for breast cancer therapy [47]. Also, Zhou
et al. applied platinated GO nanostructure for efficient gene‐
chemo combination cancer therapy [48]. The hydrophilic gra-
phene‐based yolk‐shell magnetic nanoparticles functionalized
with copolymer pluronic F‐127 (GYSMNP@PF127) has been
reported as an efficient multifunctional biomedical system for
mild hyperthermia and stimuli–responsive drug delivery [49].
Various synthetic techniques have been reported for pre-
paring metal nanocomposites, including sonochemical [50],
thermal decomposition [51], hydrothermal [52], and sol‐gel
methods [53]. In this regard, the important issue for choosing
synthetic method is reducing the cost of physical and chemical
synthesis route; meanwhile, it can produce nanocomposites
with high purity in short time. Solid‐state microwave‐assisted
method with controlling time and reaction temperature quite
provides these main purposes and is able to generate nano-
composites in narrow particle size distribution [54]. Along this
line and in the continuation of our recent works on synthesis
of NiO nanoparticles using solid‐state microwave‐assisted
method [55] and investigation of biological activity [39, 56, 57]
and drug determination [37] of the synthetic compounds, the
synthesis of Co–Sn–Cu oxides/graphene nanocomposites by
solid‐state microwave irradiation and their use as novel cata-
lysts for preparing 1,8‐dioxo‐octahydrozantenes are reported.
Also, the anti‐proliferative activity and apoptosis induction of
nanocomposites on a breast cancer cell line is investigated.
2 | EXPERIMENTAL SECTION
2.1 | Materials and methods
All chemicals were either prepared in our laboratory or were
purchased from Merck and Fluka. Reaction monitoring and
purity determination of the products were accomplished by gas
liquid chromatography or thin‐layer chromatography (TLC) on
silica‐gel polygram SILG/UV254 plates. Gas chromatography
was carried out on Shimadzu GC 14–A. 1H NMR spectra were
recorded on 400 MHz spectrometer in CDCl3. Melting points
were determined on a Fisher–Jones melting‐point apparatus. To
determine the crystalline phase, powder X‐ray diffraction
(XRD) analysis was carried on an X‐ray diffractometer with Ni‐
filtered Cu Kα irradiation (λ¼ 1.54 A°), for an angle range of 2θ
¼ 10–80°. Infrared spectrumwas carried on a Fourier transform
infrared (FT–IR) 160 spectrophotometer (Shimadzu system) by
KBr tablets. UV–Vis spectroscopy measurement at room tem-
perature (298K) was obtained by a double‐beam Shimadzu 1650
PC. The powder samples for UV–Vis analysis were dispersed in
EtOH for 25 min to make a homogeneous suspension. Field
emission scanning electron microscopic (FESEM) images were
taken on a Hitachi s4160/Japan equipped with a link energy
dispersive X‐ray (EDX) analyzer with gold coating. Trans-
mission electron microscopy (TEM, Philips CM10) was applied
at accelerating voltage of 300 kV. The sample was sonicated in
EtOH, and a drop of the suspension was dried on a carbon‐
coated microgrid for the TEM analysis. The magnetic property
of the sample wasmeasured at room temperature (298K) using a
vibrating sample magnetometer (VSM, MDKFD, Meghnatis
Kavir Kashan Co.). Ultrasonic generator was carried out on
ultrasonic probe (Top‐Sonics UPH‐400, ultrasonic technology
development Co.). A microwave oven (LG, 2.45 GHz, 900 W)
was used for the microwave irradiation. For anticancer study,
datawere analyzed by SPSS using theKruskal–Wallis test and are
presented as the means� standard deviation from at least three
independent experiments. The apoptosis was examined by flow
cytometry (Partec System, Germany). IC50 value was calculated
using probit analysis.
2.2 | Synthesis of Schiff base ligand (H2L)
4,4’‐Dibromo‐2,2’‐[cyclohexane‐1,2‐diylbis(nitrilomethanylyli-
dene)]diphenol (H2L) was synthesized according to our pre-
vious study [56]. 1,2‐Diaminocyclohexane (0.1 g, 1 mmol) was
added to 5‐bromosalicylaldehyde (0.4 g, 2 mmol) in 20 mL
MeOH. The mixture was refluxed for 1 h. The yellow powder
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was filtered off, washed with cold methanol, and dried under
vacuum over anhydrous CaCl2.
2.3 | Synthesis of precursor powders
Three solutions of H2L ligand (0.3 mmol, 0.15 g) in methanol
(10 mL) were exposed to ultrasonic irradiation, and 10 mL of a
methanolic solution of Cu(CH3COO)2.2H2O (0.14 g. 0.3
mmol) was added to each solution in a dropwise manner [57].
Then, 0.1 mmol of Co(NO3)2.5H2O with different amounts of
SnCl2.2H2O (0.005, 0.01, or 0.02 mmol) dissolved into 20 mL
of methanol was added to each above mixture under ultrasonic
irradiation (300 W) for 20 min at room temperature to form a
homogeneous light brown solution. When the pH of each
mixture was adjusted to 11 by NaOH aqueous solution (1 M), a
precipitate was formed which was then filtered off, washed
with cold methanol, and dried under vacuum over anhydrous
CaCl2. Three obtained powders were used as precursors for the
preparation of corresponding Co–Sn–Cu oxides/graphene
nanocomposites.
2.4 | Synthesis of Co–Sn–Cu oxides
nanocomposites
To prepare Co–Sn–Cu oxides/graphene nanocomposites, in
separate tests, 2 g of the above precursor samples was added to
a porcelain crucible and each one was placed in another bigger
porcelain crucible that is filled with CuO powder (microwave
absorber). The assembly was placed in a microwave oven and
exposed to microwave irradiation at 900 W (100%) in air.
Along irradiation, temperature of CuO powder increased from
room temperature to 450ºC. The temperature was determined
by a chromel–alumel thermocouple in the mixture vessel. The
generated heat was transferred to precursor sample and it was
decomposed. After 10 min, decomposition of each powder was
completed. The obtained products were cooled to room
temperature, washed with ethanol, and dried under vacuum
over anhydrous CaCl2 to produce three Co–Sn–Cu oxide
nanocomposites.
2.5 | Synthesis of GO
A double‐jacket reactor was charged with 85% phosphoric acid
(10 mL), and the circulator temperature was adjusted at 5°C.
Then, concentrated sulfuric acid (90 mL) was added to the
mixture and stirred. A well‐ground mixture of graphite (1 g,
particle size <50 µm) and potassium permanganate (5 g) was
gradually added into the above solution over a period of 2 h,
and the mixture was stirred at 5°C for 3 h. Afterwards, the
mixture was stirred with stepwise temperature rise to 25°C for
3 h and then to 55°C in 2 h. After that, the mixture was stirred
at 55°C for 12 h, cooled to 5°C, and finally poured into
crushed ice and stirred. To the resulting mixture, hydrogen
peroxide (30%) was added slowly until an ochre color was
achieved. The precipitate formed was collected by filtration,
washed twice with 50 mL of deionized water and then with
concentrated hydrochloric acid (2 � 10 mL). The washing was
repeated with deionized water until sulfate and manganese ions
were no longer present in the eluate (checked by barium and
sodium bismuthate tests). Finally, the GO product was washed
with ethanol and acetone and dried under vacuum at 70°C
overnight [58].
2.6 | Synthesis of reduced GO from GO
Reduced graphene oxide (rGO) was synthesized through the
previously reported method [59]. To a suspension of GO (500
mg) in water (20 mL) was added 50 mL of hydrazine mono-
hydrate. The mixture was refluxed for 24 h at 100ºC. The
obtained powder was washed with water and ethanol and dried
under vacuum over anhydrous CaCl2.
2.7 | Synthesis of Co–Sn–Cu oxides/
graphene nanocomposites (1, 2, and 3)
In separated tests, to 20 mL of ethanolic suspension of the
three above prepared Co–Sn–Cu oxides nanocomposites
(0.1 g), 10 mL of ethanolic solution of rGO (0.1 mg) was added
dropwise and stirred at 90ºC for 30 min and it was exposed to
ultrasonic irradiation (250 W) for 10 min. The formed powders
were separated by centrifugation and dried at 120ºC for 12 h.
The obtained products were named nanocomposites 1–3 based
on tin concentration of 0.005, 0.01, and 0.02 mmol,
respectively.
2.8 | Typical procedure for preparing
1,8‐dioxo‐octahydroxanthenes
A mixture of 3‐nitrobenzaldehyde (1 mmol), dimedone
(2 mmol), nanocomposite 3 (0.01 g), and ethanol/water (3 mL,
1:1) was prepared and stirred at room temperature. After
completion of the reaction (monitored by TLC), the catalyst
was removed by an external magnet and washed with 5 mL of
ethanol and the filtrate was concentrated on a rotary evapo-
rator under reduced pressure to yield the corresponding
product. Whenever required, the products were purified by
recrystallization from ethanol.
2.9 | Cell culture and treatment
Normal and human breast cancer cells (MCF‐7) were obtained
from National Cell Bank of Iran (NCBI), Pasteur Institute of
Iran (Tehran, Iran). The MCF‐7 cells were cultured in standard
condition (95% humidity, 5% CO2, 37ºC) in RPMI 1640
supplemented with 10% heat‐inactivated fetal bovine serum. A
200 mM solution of each nanocomposite (1–3) in 100%
dimethyl sulfoxide (DMSO) and different concentrations was
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prepared with the RPMI 1640; the final concentration of
DMSO was less than 0.02% in both control and treated cells.
2.10 | Cell viability assay
MCF‐7 were seeded in a concentration of 8� 103 cells per well
in 96–well plates for 24 h before treatment and exposed to
different concentrations of nanocomposites (0–500 μg/mL)
for 24 and 48 h. Cell viability was then examined by the
colorimetric assay using the 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐
diphenyltetrazolium bromide (MTT) assay, according to the
manufacturer's instruction (Sigma Aldrich, USA). Briefly, after
different incubation times, cells were washed twice with
phosphate‐buffered saline (PBS) and MTT solution prepared
in PBS (5 mg/mL) was added to each well to the final con-
centration of 0.5 mg/mL in no‐phenol red RPMI and was
incubated for 3 h in a dark place. After washing with PBS, 100
μL of DMSO was added to each well, and absorbance was
measured at 570 nm by an Elisa reader (stat fax‐2100 aware-
ness). Viably of each group was measured according to the
absorbance compared with control.
2.11 | Apoptosis assay
MCF‐7 cells were seeded in 6–well plates at a density of 1� 106
cells per well, grown for 24 h before treatment with nano-
composites at IC50 value for 48 h. The apoptosis was examined
by flowcytometry using theAnnexin V‐FITC/propidium iodide
(PI) apoptosis kit (BD Biosciences), according to the manufac-
turer's instruction. Briefly, MCF‐7 cells were washed with cold
PBS and were then resuspended in 1 mL of 1x binding buffer
(providedwith kit) at density of 10� 106 cells/mL. 100 µL of cell
suspension was incubated with 5 µL of Annexin V‐FITC and PI
for 20 min in the dark at room temperature, and then examined
by flow cytometry. The percentage of cells in different stages
(apoptosis and necrosis) was examined by FlowJo 7.6 software.
At least 12,000 events were recorded and represented as dot
plots.
3 | RESULTS AND DISCUSSION
3.1 | Synthesis and structural
characterization of nanocomposites
By solid‐state microwave irradiation, three nanocomposites
(1, 2, and 3) were prepared in a short time (Scheme 2). For
this purpose, first a Schiff base ligand (H2L) was prepared
using 1,2‐diaminocyclohexane and 5‐bromosalicylaldehyde
which was then reacted with Cu(CH3COO)2.2H2O, Co
(NO3)2.5H2O, and SnCl2.2H2O at different concentrations
to produce three precursors. Afterwards, each precursor was
exposed to microwave irradiation to yield their corre-
sponding nanocomposites. However, we observed that the
precursors remained unchanged for 30 min, indicating that
they do not absorb microwaves energy. Therefore, reaction
requires a secondary irradiation absorber. For this purpose,
CuO powder was used. Then, each precursor was
completely decomposed through the absorption of heat
from the hot CuO and the corresponding nanosized Co–
Sn–Cu oxides/graphene nanocomposites were formed.
Decomposition of each precursor was companied by the
release of different gases such as N2, NO, N2O, and H2O
vapors. After the synthesis of nanocomposites, the Co–Sn–
Cu oxides/graphene nanocomposite 3 (with 0.02 mmol of
Sn ion, abbreviated hereinafter to nanocomposite 3) was
considered as representative sample for characterization by
different analyses.
Figure 1(a) shows XRD pattern of the corresponding
precursor for nanocomposite 3. This pattern manifested that
the particles were in nanometer scale. The main diffraction
peaks were observed at 2θ ¼ 27.1705° and 45.0807°. The
average particle size was calculated to be about 42.72 nm, by
applying a full width at half maximum and the value of 2θ
of the characteristic peak of the XRD pattern using the
Debye–Scherrer equation [60]. Figure 1(b) displays the XRD
pattern of nanocomposite 3 at the power level of 900 W for
10 min in a microwave cavity. All the diffraction peaks of
the XRD pattern could be indexed to the monoclinic CuO
phase (space group: C2/c; No. 15, JCPDS Card No. 80‐
1268) at 2θ ¼ 35.5806°, 38.7820°, and 48.8044°, which can
be perfectly related to (–1 1 1), (1 1 1), and (–2 0 2) crystal
planes, respectively. Lattice constants of the CuO phase were
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diffraction peaks of Co3O4 (JCPDS Card No. 74‐2120) and
SnO2 phases (JCPDS Card No. 88‐0287) were observed in
this pattern. As shown in Figure 1(b), no amorphous pha-
se, composed of rGO, was detected [61]. No characteristic
XRD peaks arising from precursor were observed,
indicating the formation of pure nanocomposite 3. The
average particle size of the synthesized nanocomposite 3
was determined using the Debye–Scherrer formula to be
33.92 nm.
The FT–IR spectra of nanocomposite 3 and its corre-
sponding precursor are shown in Figure 2. In IR spectrum
of the precursor (Figure 2(a)), the band at 1607.72 cm–1 is
related to the azomethine group (C¼N) which has shifted to
a lower frequency compared to the copper (II) complex of
Schiff base ligand (H2L) (1630 cm
–1) [57] due to the pres-
ence of cobalt and tin in the compound. In the IR spectrum
of nanocomposite 3 (Figure 2(b)), a strong band was
observed at around 571 cm–1 which can be assigned to the
M–O bond (M ¼ Cu, Co, and Sn) [57, 62]. The C–H and
C–O stretching vibrations due to graphene sheets appeared
at 2925 and 1383 cm–1, respectively [63]. Also, the appear-
ance of bands at 3432 and 1631 cm–1 was assigned to the
stretching and bending vibrations of the water molecules
absorbed by the sample or KBr [57]. The disappearances all
characteristic bands of the precursor in the IR spectrum of
nanocomposite 3 demonstrated complete decomposition of
the precursor into nanocomposite 3 by the solid‐state mi-
crowave‐assisted method.
The morphology of nanocomposites and their corre-
sponding precursors were surveyed by the FESEM analysis
(Figure 3). The FESEM images of the precursor of nano-
composite 3 show nanorods which were loosely aggregated
(Figure 3(a) and (b)). As shown in Figure 3(c) and (d), the
morphology of nanocomposite 3 is semispherical shape. The
particle size distribution of the precursor and nanocomposite 3
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S C H E M E 2 The synthetic routes for Co–Sn–Cu oxides/graphene
nanocomposites
F I G U R E 1 XRD pattern of nanocomposite 3 (b) and its
corresponding precursor (a)
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was found to be 50–60 � 0.8 and 30–40 � 0.5 nm, respec-
tively. These results are in good agreement with the XRD
analysis. The striking difference between the size and shape of
nanocomposite 3 with its corresponding precursor showed
that their structures are quite different and confirmed that
decomposition of precursor into the product particles is
complete. Therefore, solid‐state microwave irradiation is a
beneficial method for the synthesis of varied nano‐sized
compounds in high purity. The difference between this method
and the conventional heating methods results from the dif-
ference in the mechanism of the reactions. The solid‐state
microwave irradiation involves converting electromagnetic
energy into heat by fast kinetics of the molecules. The elec-
tromagnetic energy arises from interaction of microwave
wavelengths with the reactants at the molecular level [64].
These extreme conditions lead to solid‐state decomposition
reactions and the formation of nano‐sized particles in different
morphologies.
The morphology and particle size of the synthesized
nanocomposites were further investigated by TEM analysis.
TEM images of nanocomposite 3 are given in Figure 4 at
different magnifications. The images showed the spherical
shape of particles with the particle size distribution of 30–40 �
0.5 nm, similar to that obtained using the XRD and FESEM
analysis.
Figure 5 shows the EDX analysis of nanocomposite 3 that
confirms the presence of Co, Cu, Sn, C, and O elements in this
nanocomposite. The Si and Au signals were observed due to
the coating material of the instrument. Pleasingly, EDX results
(inset in Figure 5) are in close agreement with the ratios used in
the synthetic processes. Hence, these results show that nano-
composite 3 was prepared in high purity by the presented
solid‐state microwave method.
It is believed that the magnetic property of nanomaterials is
highly dependent on the type of sample shape, size of particles,
magnetization direction, and synthetic method. The variation
in magnetization (M) as a function of applied field (H) at room
temperature for nanocomposite 3 is depicted in Figure 6 and
shows a superparamagnetic behavior of the nanocomposite
(Mr ¼ 0.24 emu/g).
F I G U R E 3 FESEM images of the
corresponding precursor for nanocomposite 3 (a, b)
and nanocomposite 3 (c, d) at different
magnifications
F I G U R E 4 TEM images of nanocomposite 3 at
different magnifications
202 - PARVANAK BOROUJENI ET AL.
The electronic property of the synthesized nanocomposites
was surveyed by UV–Vis analysis. Figure 7 shows the elec-
tronic spectrum of the corresponding precursor for nano-
composite 3. The band at 247 nm was related to the π–π*
transition of the aromatic rings contained in ligand structure.
The bands at 393–422 nm were attributed to the MLCT (metal
ligand charge transfer) and LMCT (ligand metal charge trans-
fer) transitions [65, 66]. These bands showed a shift toward the
copper (II) complex of Schiff base ligand (H2L) [57] due to the
presence of tin and cobalt ions.
Figure 8 shows electronic spectra and the (Ahυ)2–hυ curves
of the nanocomposites 1–3. In Figure 8(a), the observed bands
(<200 nm) of the nanocomposites are due to the electron
transitions from Cu (3d) and O (2p) orbitals [67] and have
highest intensity for nanocomposite 3. These bands showed a
blue shift compared with pure CuO nanoparticles [68, 69], due
to the presence of Co and Sn ions. The band gap (Eg) of the
synthesized nanocomposites can be obtained by the equation:
(Ahυ)2 ¼ B (hυ–Eg), where A, hυ, and B represent the
F I G U R E 5 EDX spectrum of nanocomposite 3
F I G U R E 6 Magnetization versus applied magnetic field at room
temperature for nanocomposite 3
F I G U R E 7 Electronic spectrum of the corresponding precursor of
nanocomposite 3
F I G U R E 8 Electronic spectra of the nanocomposites 1–3 (assigned 1
(blue line), 2 (red line), and 3 (green line)) (a) and their corresponding
(Ahʋ)2–hʋ curves (b)
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absorption coefficient, the energy of photon, and a constant
depending on the type of materials, respectively. Figure 8(b)
shows the (Ahυ)2–hυ curves for the nanocomposites 1–3. The
band gaps of the nanocomposites 1–3 were estimated as 4.1,
3.7, and 3.8 eV, respectively, by extrapolation of the
corresponding curves. The value of band gaps for three
nanocomposites has a slight shift relative to each other, most
probably due to their difference in particle size and the tin
content. Based on these results, it can be predicted that the
synthesized nanocomposites can be used as semiconductors.
3.2 | Catalytic application of the
nanocomposites
After synthesis and characterization of the nanocomposites,
their catalytic activity for preparing 1,8‐dioxo‐octahydrox-
anthenes was examined (Scheme 3). For this purpose, the
condensation reaction of 4‐bromobenzaldehyde with dime-
done was chosen as a model reaction for the optimization of
the reaction conditions. As it can be seen from Figure 9a,b,
3,4,6,7‐tetrahydro‐3,3,6,6‐tetramethyl‐9‐(4‐bromophenyl)‐2H‐
xanthene‐1,8(5H,9H)‐dione product was obtained in 97% yield
in EtOH/H2O (1:1) as green solvents after 20 min at room
temperature in the presence of 0.1 g of nanocomposite 3. No
significant difference was found between catalytic activities of
nanocomposites 1–3. Thus, we typically applied this optimized
condition for the reaction of a variety of aromatic aldehydes
with dimedone in the presence of nanocomposite 3. The re-
sults showed that both aldehydes bearing electron‐donating,
electron‐withdrawing, and halogen substituents gave the
desired 1,8‐dioxo‐octahydroxanthenes in high‐to‐excellent
yields (Table 1, entries 1–7, 10–12). Acid‐sensitive aldehydes
such as furan‐2‐carboxaldehyde and thiophene‐2‐carbox-
aldehyde (entries 8, 9) reacted well and gave the corresponding
S C H E M E 3 The catalytic performance of Co–Sn–Cu oxides/
graphene nanocomposites in the green synthesis of 1,8‐dioxo‐
octahydroxanthenes
F I G U R E 9 The screening of the solvent nature (a) and catalyst
amount (b) on the reaction of 4‐bromobenzaldehyde (1 equivalent) with
dimedone (2 equivalents) after 20 min at room temperature catalyzed by
nanocomposite 3
TA B L E 1 Preparation of 1,8‐dioxo‐octahydroxanthenes from the
reaction aldehydes with dimedone using nanocomposite 3a
No. Ar Time (min) Yield (%)b mp (oC) (lit.) [Ref.]
1 4‐NO2C6H5 14 97 224–227 (226–228) [12]
2 3‐NO2C6H5 15 97 167–170 (170–171) [11]
3 2,4‐Cl2C6H4 18 96 250–253 (247–248) [11]
4 4‐CNC6H5 16 96 213–217 (217–221) [19]
5 4‐ClC6H5 19 95 225–229 (237–238) [11]
6 4‐BrC6H5 20 97 235–237 (240–241) [11]
7 C6H5 20 96 199–203 (205–206) [11]
8
O
20 94 60–63 (62–63) [13]
9
S
20 94 160–163 (160–165) [19]
10 4‐MeC6H5 22 93 210–213 (212–214) [10]
11 4‐HOC6H5 22 93 238–241 (244–246) [10]
12 4‐MeOC6H5 24 93 239–243 (242–245) [10]
aAll reactions were carried out in EtOH/H2O (1:1) at room temperature in the presence
of nanocomposite 3 (0.1 g).
bIsolated yield. All products are known compounds and were identified by comparison
of their physical and spectral data with those of the authentic samples.
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products in high yields. In the absence of the catalyst, no
products were formed. All the reactions were clean as indicated
by TLC and the only work‐up being the easy removal of the
catalyst using an external magnet and then evaporation of re-
action solvent. Figure 10 shows 1H‐NMR spectrum of 3,4,6,7‐
tetrahydro‐3,3,6,6‐tetramethyl‐9‐(4‐bromophenyl)‐2H‐xan-
thene‐1,8(5H,9H)‐dione.
A plausible mechanism for the condensation reaction of
aromatic aldehydes with dimedone is as follows (Scheme 4):
(1) the reaction of a molecule of enolized dimedone with aro-
matic aldehyde activated by the catalyst, which yields interme-
diate (I); (2) intermediate (I) undergoes dehydration to give the
intermediate (II); (3) nucleophilic addition of second molecule
of dimedone on activated intermediate (II), in the Michael
addition fashion, affords uncyclized adduct 2,2’‐aryl‐methylene
bis(3‐hydroxy‐2‐cyclohexene‐1‐one) (III), which produces
1,8‐dioxo‐octahydroxanthenes after intramolecular cyclo-
dehydration [10, 11]. As it can be seen from Table 2, aromatic
aldehydes bearing the electron withdrawing groups (entries 1,2)
react with dimedone faster than those containing electron
releasing groups (entries 10–12). According to the above‐
mentionedmechanism, this could be due to the greater tendency
of the intermediate II to react with dimedone in the presence of
the electron withdrawing groups substituted on arylaldehydes.
To evaluate the level of reusability and recycling of the
catalyst, a series of catalytic cycles were run. In each cycle, the
catalyst was separated by an external magnet, washed with
ethanol, and reused. As shown in Figure 11, the catalyst can be
reusable with negligible loss in its activity. The activity loss is
probably due to loss of the active sites of catalyst by water or
reaction products during separation and washing cycles.
To find out whether the reaction takes place in the solid
matrix of Co–Sn–Cu oxides/graphene nanocomposites or
whether any other species (simply released in the reaction
medium) are responsible in the synthesis of 1,8‐
dioxo‐octahydroxanthenes, Co–Sn–Cu oxides/graphene
nanocomposite (0.1 g) was added to a solution of aldehyde
(1 mmol) and dimedone (2 mmol) in EtOH/H2O (1:1) and
the mixture was stirred at room temperature for 4 h. Then,
the catalyst was removed by an external magnet, and the
filtrate showed no catalytic activity for the preparation of
1,8‐dioxo‐octahydroxanthenes. These observations indicate
that Co–Sn–Cu oxides/graphene nanocomposites are stable
under the reaction conditions; there is no danger of leaching
during reactions.































S C H E M E 4 The proposed mechanism for the synthesis of 1,8‐dioxo‐
octahydroxanthenes catalyzed by nanocomposite 3
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Finally, the catalytic performance of nanocomposite 3 was
compared with other catalysts employed for the synthesis of
1,8‐dioxo‐octahydroxanthenes (Table 2). In addition to having
the general advantages attributed to heterogeneous catalysts,
nanocomposite 3 has shown superiority over the other cata-
lysts in terms of reaction temperature and time.
3.3 | Anti‐cancer study
3.3.1 | Effect of nanocomposites on MCF‐7 cell
proliferation
Some parameters such as shape, size, dimensions, surface
structure, density, chemical composition, and solubility play
important role for defining the toxicity of nanocompounds
[70, 71]. The effective anticancer agents are the compounds
that have the most toxicity against cancerous cells whereas
the lowest toxicity to normal cells. In this study, to deter-
mine the effect of nanocomposites on viability of MCF‐7
cells, cells were incubated for 24 and 48 h in the absence or
presence of prepared nanocomposites at different concen-
trations (0–500 μg/mL). The optical density obtained from
the absorption at 570 nm was converted to a percentage.
Figure 12 shows the reduction of cell viability as concen-
tration increased (dose‐dependent). A significant reduction
of MCF‐7 cell viability was also observed with a time‐
dependent manner at a specific concentration. Data showed
that nanocomposite 1 is more powerful cytotoxic effect than
others both in 24 and 48 h. IC50 (inhibition concentration)
values were measured by probit analysis and were 61.82 �
3.21, 205.73 � 4.25, and 344.03 � 6.32 μg/mL in 24 h, and
also 43.28 � 4.28, 78.83 � 5.01, and 135.58 � 9.84 μg/mL
in 48 h for nanocomposites 1–3, respectively. Also, IC50
value for normal cell line was investigated. The human
dermal fibroblasts (HDF) line was chosen, and values of
IC50 were measured as 423.40 � 11.53 and 444.17 � 13.34
μg/mL for nanocomposites 2 and 3, respectively, in 24 h. In
the case of nanocomposite 1, IC50 value was not observed
after this time. IC50 value was investigated as 359.2 � 13.5,
92.06 �1.75, and 189.51�13.59 μg/mL for nanocomposites
1–3, respectively, in 48 h. The results were shown that
nanocomposite 1 has less toxicity against normal cell (as
shown in Figure 13. In addition, anti‐cancer property of
TA B L E 2 Comparison of the efficiencies of a number of different reported catalysts with that of nanocomposite 3 in the reaction of benzaldehyde with
dimedone
No. Reaction conditions Time (min) Yield (%)a
1 NHSO4–SiO2, CH3CN, reflux 210 95 [9]
2 SmCl3, solvent‐free, 120oC 540 98 [10]
3 [Et3NH][HSO4], solvent‐free, 100oC 20 94 [11]
4 Fe3O4 nanoparticles, solvent‐free, 100oC 30 89 [12]
5 Mg–Al hydrotalcite, H2O, reflux 180 85 [13]
6 Sulfated zirconia, EtOH, 70oC 480 95 [14]
7 Trichloromelamine, solvent‐free, 110oC 30 82 [15]
8 Cu(II)‐Fur‐APTES/GOb, EtOH/H2O, 50oC 30 95 [16]
9 Cerric ammonium nitrate, 2‐propanol, USc, 50oC 35 98 [17]
10 Ionic liquid [H‐NMP]–[HSO4]þd, USc, H2O, room temperature 50 86 [18]
11 Cellulose/Al2O3‐[MeIm]Cl‐XAlCl3e, EtOH, room temperature 25 91 [19]
12 Carbon nanotube‐BuSO3H, EtOH, room temperature 30 95 [20]
13 Co–Sn–Cu oxides/graphene nanocomposite 3, EtOH/H2O, room temperature 20 96
aIsolated yield.
bFurfural‐imine‐functionalized graphene oxide‐copper oxide.
cUltrasound irradiation.
d2‐Pyrodidonium hydrogen sulfate.
eCellulose aluminum oxide composite supported imidazolium chloroaluminate ionic liquid.
F I G U R E 1 1 Reusability of nanocomposite 3 (0.1 g) for the reaction of
4‐bromobenzaldehyde with two equivalents of dimedone in EtOH/H2O
(1:1) at room temperature after 20 min
206 - PARVANAK BOROUJENI ET AL.
CuO nanoparticle as negative control [57] was studied
against MCF‐7 cell line. IC50 value was 206.36 �10.21 in 48
h, whereas it was not observed in 24 h. Thus, the presence
of Co and Sn in chemical structure (appropriate amount) of
these nanocomposites is an effective parameter.
F I G U R E 1 2 Cytotoxic effect of the nanocomposites and CuO
nanoparticle as negative control on MCF‐7 cell line by the MTT assay. The
data are representative of three independent experiments (mean � SD)
F I G U R E 1 3 Cytotoxic effect of the nanocomposites and CuO
nanoparticle as negative control on HDF cell line by the MTT assay. The
data are representative of three independent experiments (mean � SD)
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3.3.2 | Effect of the nanocomposites on MCF‐7
cell apoptosis
To assess whether nanocomposites could induce apoptosis
in MCF‐7 cells, apoptosis induction was determined by an
Annexin‐V‐FITC/PI apoptosis detection kit. MCF‐7 cells
were incubated for 48 h at IC50 value. Cells that were
positive just for Annexin‐V and those that were positive
both for Annexin‐V and PI were considered as early and
late apoptotic cells, respectively. As shown in Figure 14,
nanocomposites could induce apoptosis in treated cell
and nanocomposite 1 was more powerful in inducing
apoptosis, compared with other nanocomposites and CuO
nanoparticle.
Finally, cells were exposed to IC50 value of nano-
composites for 48 h. Dot plots show the results of a repre-
sentative apoptosis assay. The number of cells in apoptosis
indicated as percentage relative to the total cell number.
Treated cells with nanocomposites at IC50 value showed a
significant increase in the amount of apoptotic cells compared
with the control group just in nanocomposite 1 (*P<0.05)
(Figure 15).
So far, many investigations were done based on metallic
nanoparticles (metal oxides, metallic nanocomposites, mag-
netic nanoparticles, graphene‐based nanoparticles etc.) to find
out effective anticancer drugs that play an important role in
the apoptosis [72–77]. The presence of anionic phospho-
lipids in cancer cells causes negative zeta potential that
absorb into positively charged nanoparticles by strong elec-
trostatic interaction [78, 79]. The nanoparticles cause the
inflammation, damage of DNA or cell membrane, and
eventually cell death occurs [80]. In this work, we prepared
Co–Sn–Cu oxides/graphene nanocomposites, for the first
time, via solid‐state microwave method as a new, simple, and
F I G U R E 1 4 Apoptosis induction of the nanocomposites (assigned 1, 2, and 3) and CuO nanoparticle as negative control (assigned 4)
F I G U R E 1 5 Effect of the nanocomposites (assigned 1, 2, and 3) and
CuO nanoparticle as negative control (assigned 4) on apoptosis after 48 h.
The percentage of cells in early and late apoptosis was considered as
apoptosis
208 - PARVANAK BOROUJENI ET AL.
fast strategy and their anti‐cancer effects in MCF‐7 cells were
investigated via apoptosis induction. The results showed that
nanocomposite 1 was more potent than copper nanoparticles
(CuNP, IC50 ¼ 85 µg/mL) [81], silver nanoparticles
(IC50 ¼ 90 µg/mL) [82], Fe3O4/Ag nanocomposite (IC50¼
135 μg/mL) [83], and copper sulfide quantum dots
(CuSQDs) loaded nano‐GO (IC50 ¼ 100 µg/mL) [84]. The
superiority of our introduced nanocomposites may be due to
different factors such as type and ratio of elements that
resided in nanocomposite, type of precursor, as well as
synthetic method. We anticipate that the solid‐state micro-
wave method, used for the preparation of the present
nanocomposites 1–3, would be the newly developed route
for the synthesis of different anticancer drugs based on
nanostructured materials. In addition, as mentioned in the
Introduction section, graphene and its derivatives have
supreme physicochemical and pharmaceutical properties,
which make them good candidate for research in cancer
therapy, recently [85, 86]. The biodegradation of graphene
nanomaterials by microbes and enzymes has also been
documented [87, 88]. Therefore, considering the presence of
the Co–Sn–Cu oxides on graphene surface in the presented
Co–Sn–Cu oxides/graphene nanocomposites and obtaining
very good results in the context of anticancer activity at this
stage, we predict that these nanocomposites are potential and
promising materials for the preparation of anticancer drugs
after taking part in clinical trials.
4 | CONCLUSIONS
In this work, we proposed solid‐state microwave irradiation as
a simple, efficient, safe, fast, and environmental friendly
method for the synthesis of pure Co–Sn–Cu oxides/graphene
nanocomposites. This method did not require fuel, solvent,
surfactant, any expensive materials, and any complex in-
struments. The nanocomposites were used as green catalysts
for preparing 1,8‐dioxo‐octahydroxanthenes at room temper-
ature. The catalysts can be easily separated from reaction
media using an external magnet and are reusable. Simple work‐
up procedure, easy handling of the catalyst, high yields, and
short reaction times are the other obvious advantages of the
present method. Following these results, the researchers
further investigated anti‐cancer activity of the nanocomposites.
The results of our study showed that nanocomposites can
silence cell proliferation with a time‐ and dose‐dependent
manner. Also, the results demonstrated that nanocomposites
can induce apoptosis in breast cancer cell line which is an
advantageous effect of anti‐cancer therapy. The results indi-
cated that nanocomposite 1 was a more powerful apoptosis
inducer than other nanocomposites in MCF‐7 cells. On the
basis of the results, following 48 h incubation, it derived
almost 30% of cells to apoptosis at IC50 value concentrations.
Pleasingly, photocatalyst properties of the synthesized nano-
composites are under investigation and will be reported in due
course.
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